Cost-conscious buyers have been and continue to be more likely to purchase lower-cost, higher-earning savings products from life insurers as an alternative investment vehicle to build their assets Read More

Bancassurance growth in Asia has been surging over the past few years, strongly boosted by the main sizable bancassurance deals signed - several of which have valuations in the billions. Read More

Insurers first require good answers to several complex questions around wellness’ frictional areas of value, economics, and technology, as well as around issues of trust and engagement.

Read More

RGA's Paul Sauvé, Senior Vice President, EMEA, Global Financial Solutions offers three observations about the evolution of Solvency II regulation over the past two decades and the emergence of cost-efficient reinsurance solutions for risk management.  Read More

Many insurance advisors might also say that today’s full underwriting process is not only long, but can be daunting for the advisor as well as the applicant.

Read More

Amid rising costs and evolving needs, how can group insurers improve their competitive positions – and protect profitability? Read More

In uncertain times, the certainty of statistics can seem like a balm, but is the concept of statistical significance misunderstood — and misused? In an issue of the Society of Actuaries' publication Predictive Analytics and Futurism, RGA's Rosmery ...

Read More

Claims professionals can benefit from a greater understanding of the role and efficacy of radiosurgery, particularly when used for conditions with complex neurological causes and in cases that might formerly have been deemed untreatable.

Read More

Pressure continues to build on maximum underwriting guidelines for group life and group long-term disability (LTD) policies in employee benefit plans in the small case marketplace (i.e., employers with <200 lives). This paper discusses causes and consequenc... Read More

The development of new and innovative products is a key success factor for insurers. One such product is Cancer Reimbursement insurance. This article will address aspects of this product’s development journey. Read More

The clinical understanding and treatment of chronic lymphocytic leukemia (CLL), the most prevalent adult leukemia in the West, has experienced several advances over the past decade. This article examines these advances and prognostic implications for insurers... Read More

Review the role of genetics in chronic lymphocytic leukemia and explore Cancer Reimbursement products.
Read More

Will consumer behavior change as genetic testing becomes more accessible? Read More

Genomic tests and their outcomes are creating important considerations for insurers – especially in underwriting and claims. Read More

What are the underwriting implications of democratising health records and are underwriters ready? Read More

Explaining a claims decision, a specific policy clause or simply requesting additional information can create confusion and frustration for the claimant if not done clearly. Here are some simple suggestions. 

Read More

This article examines some of suicide’s impact on the U.S. life insurance industry, and also briefly looks at current practices and thoughts regarding suicide prevention. Read More

Annuities can provide a guaranteed fixed income for life in exchange for a lump-sum payment, making them a good way to meet the first two needs. This article will discuss the growth and development of the U.K.’s enhanced annuity market, the recent legislative changes re... Read More

This article was developed with the support of RGA Australia and New Zealand and the RGA Hong Kong, Korea and Japan offices and addresses cancer products throughout Asia.  Read More

This article explores the opportunity to revolutionise financial services for mass emerging markets through microinsurance.   Read More